The chart of Vimta labs has previously been shared in 52 weeks high thread. There is a long term inverted head and shoulders pattern. Stock price had faced resistance in the 310-330 range twice in 2018, (formed a left shoulder) and once in 2021 ( right shoulder) and ultimately crossed this level in Oct 2021 and went on to post a high of 444, only to come down and retest the previous resistance zone. In recent weeks stock price has fallen to levels of 310-330 and successfully taken support at that zone. Now it seems to be showing good resilience in an overall weak market.
Fundamentally speaking the results for last few quarters have been quite good. q4 has shown good topline and bottomline growth. In recent concall, the management seems confident of achieving aspirational target of a topline of 500 crores by FY 25, from current levels of 275 crores. Nearly doubling of revenues of the company in a matter of three years. If what management expects materialises, then stock price can povide good returns from hereon.
How frequently they conduct concalls is up to them. And as she says if she has something new and exciting to share, she will share it outside the ambit of concalls and AGMs. So I think that’s okay. As long as they remain focussed on taking the company on the growth path, I am okay with even one concall (or no concall 
) a year.